Centum Electronics (517544) Q2 24/25 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 24/25 earnings summary
25 Oct, 2026Executive summary
Q2 FY25 consolidated operational revenue was INR 2,598 Mn, up 4.7% YoY; EBITDA was INR 203 Mn, up 18%, and PAT was a loss of INR 3 Mn.
H1 consolidated operational revenue was INR 5,053 Mn, up 1.9% YoY; EBITDA was INR 358 Mn, down 8%, and net loss was INR 41.55 Mn.
Order book stood at INR 17,720 Mn at 30 Sep 2024, excluding EMS client forecasts and signed LOIs for Transportation products.
Financial highlights
Q2 standalone revenue was INR 1,667 Mn, up 4.2% YoY; EBITDA was INR 205 Mn, down 2.8%, and PAT was INR 96 Mn.
H1 standalone revenue was INR 2,996 Mn; EBITDA was INR 333 Mn, down 13.5%, and PAT was INR 141 Mn, down 15.6%.
Q2 consolidated PBT was INR 28.97 Mn, versus a loss of INR 21.19 Mn YoY.
Consolidated finance cost was INR 77 Mn in Q2, down 15.4% YoY; H1 finance cost was INR 153 Mn, down 11.0%.
Outlook and guidance
FY25 consolidated revenue growth target remains 18%-20% on a gross accounting basis; net accounting would imply 14%-15% growth.
FY25 EBITDA target is INR 130 crore, excluding other income; stronger H2 performance is expected from BTS deliveries, EMS and improved subsidiary performance.
Management expects EBITDA margins of 14%-15% over the next 2-3 years through stepwise improvement; BTS deliveries are seasonal and lumpy.
The subsidiary is expected to contribute positively in Q3 and Q4; Q2 is seasonally slowest and Q4 typically strongest due to working days.
Latest events from Centum Electronics
- Q2 revenue rose 52% YoY as the order book reached Rs 19.5 billion.517544
Q2 26/27 - Adjusted revenue grew 7%; H2 BTS deliveries are expected to support recovery.517544
Q1 24/25 - Ausar provision and Canadian losses weighed on consolidated results despite standalone growth.517544
Q3 24/25 - Q4 margins rebounded as the order book supported FY26 growth targets despite subsidiary losses.517544
Q4 24/25 - Revenue and margins improved YoY, while subsidiary losses and ER&D delays persist.517544
Q1 25/26 - Standalone growth strengthened, while subsidiary losses constrained consolidated margins.517544
Q2 25/26 - Standalone growth and defense prospects offset overseas restructuring losses and impairments.517544
Q3 25/26 - Revenue and order growth were offset by overseas restructuring losses.517544
Q4 25/26 - Order book rose 31% as Q1 margins softened and reported profit included discontinued operations.517544
Q1 26/27